Description
COMPATIBILITY TESTING
Base award description: COMPATIBILITY TESTING 673-C90340
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-01-30+$378,658= $378,658
- Mod 12009-03-02+$0= $378,658
- Mod 22009-12-31+$40,000= $418,658
- Mod 32010-01-30+$80,000= $498,658
- Mod 42010-03-19+$78,588= $577,246
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-01-30 | +$378,658 | $378,658 | COMPATIBILITY TESTING 673-C90340 |
| Mod 1· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2009-03-02 | +$0 | $378,658 | IT REQUIREMENTS MOD |
| Mod 2· EXERCISE AN OPTION | 2009-12-31 | +$40,000 | $418,658 | COMPATIBILITY TESTING-OPTION TO EXTEND SERVICES VA673-C00293 |
| Mod 3· EXERCISE AN OPTION | 2010-01-30 | +$80,000 | $498,658 | COMPATIBILITY TESTING EXERCISE OPTION TO EXTEND SERVICES VA673-C00293 |
| Mod 4· EXERCISE AN OPTION | 2010-03-19 | +$78,588 | $577,246 | COMPATIBILITY TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SX3XGHRJMNQ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0419 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $792,973 | FY2026 |
| 36C24826N0399 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6506 · BLOOD AND BLOOD PRODUCTS | $354,763 | FY2026 |
| 36C24826N0424 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $268,659 | FY2026 |
| 36C24826N0400 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $314,881 | FY2026 |
| 36C24826N0347 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $619,287 | FY2026 |
| 36C24826D0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q301 from 673-TAMPA (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA673C20022 | EUROFINS VIRACOR, LLC | 673-TAMPA | $44,269 | FY2012 |
| VA673C20023 | IRIS INTERNATIONAL, INC. | 673-TAMPA | $50,436 | FY2012 |
| VA673C20020 | UNIVERSITY OF SOUTH FLORIDA | 673-TAMPA | $69,730 | FY2012 |
| VA673C10136 | ARUP LABORATORIES INC | 673-TAMPA | $83,686 | FY2011 |
| VA673C10201 | ACCUPATH DIAGNOSTIC LABORATORIES INC | 673-TAMPA | $33,462 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA248P0921_3600_-NONE-_-NONE- · retrieved 2026-09-26.